Antibiotics Consumption Growing at Alarming Rate, Study Finds

The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Ga., on May 21, 2024. Madalina Vasiliu/The Epoch Times

The use of antibiotics has shot up over recent years and poses an “escalating crisis” that must be addressed swiftly, according to a new study published in the Proceedings of the National Academy of Sciences on Nov. 18.

The peer-reviewed study looked at antibiotic consumption levels in 67 nations between 2016 and 2023. It found that consumption rose 16.3 percent during this period, from 29.5 billion to 34.3 billion average daily doses taken worldwide per year.

The U.S. Centers for Disease Control and Prevention (CDC) calls antimicrobial resistance “one of the world’s most urgent public health problems.” Infections resistant to drugs “can be difficult, and sometimes impossible, to treat,” according to the CDC.

Such infections can result in higher rates of mortality, increased treatment costs, and longer hospital stays.

Globally, antimicrobial resistance is linked to 5 million deaths every year.

While the COVID-19 pandemic disrupted antibiotic use temporarily, “global consumption has rebounded quickly and continues to rise at an alarming rate,” Dr. Eili Klein, lead author of the study, said in a Nov. 18 statement.

“To address this escalating crisis, we must prioritize reducing inappropriate antibiotic use in high-income nations while making substantial investments in infrastructure in low- and middle-income countries to curb disease transmission effectively.”

During the COVID-19 pandemic, antibiotic consumption was “significantly reduced,” especially in high-income countries, the study stated. However, there were “rapid increases” in usage among middle-income countries in 2021.

For the 2016 to 2023 period, the top five largest percentage increases in antibiotic consumption occurred in middle-income nations.

The highest increase among lower-middle-income countries was in Vietnam, where the rate of consumption more than doubled. West Africa came in second in rate of increase.

In upper-middle-income countries, the largest jump was in Thailand, followed by the countries of Central America, with Malaysia in the third spot.

Researchers pointed out that while several factors could be driving up antibiotic consumption, economic growth is “likely the most important factor in lower-income settings.”

“As countries grow economically and attempt to break out of the poverty cycle, they may be at risk for inappropriate antibiotic use,” they noted.

The study estimated that the total global antibiotic consumption in 2023, including nations that do not belong to the 67 countries analyzed in the paper, was 49.3 billion daily doses.

“By 2030, we project that, without reductions in rapidly developing nations, such as investments to improve infrastructure, particularly water and sanitation, along with improved access to vaccination, global antibiotic consumption will increase by 52.3 percent” from the 2023 level, the study stated.

Some researchers declared competing interests in the study. Two were employees of the biopharma company GSK group. Another researcher was a GSK employee when the study began but is currently working for Moderna. A fourth individual had earlier received research support or personal fees from GSK, Pfizer, Merck, and Sanofi-Pasteur for vaccination research.

Risks of Antibiotic-Resistant Pathogens

A September report published in The Lancet warned that antibiotic-resistant infections could claim up to 40 million lives by mid-century.

“The continued overuse of antimicrobials, both in human health and in agriculture, produces an environment that selects for increasingly resistant bacteria,” researchers said.

The study suggested developing treatments aimed at gram-negative bacteria—microbes whose cell wall structures make them resistant to several antibiotics.

The CDC estimates that the United States sees more than 2.8 million antimicrobial-resistant infections annually, with more than 38,000 deaths.

Antimicrobial resistance develops as part of a pathogen’s evolution.

“Antibiotics and antifungals kill some germs that cause infections, but they also kill helpful germs that protect our body from infection. Antimicrobial resistance accelerates when antibiotics and antifungals pressure bacteria and fungi to adapt,” the CDC says.

“The antimicrobial-resistant germs survive, multiply, and spread to other germs. These surviving germs have resistance traits in their DNA that can spread to other germs.”

Antibiotic use among infants may also lead to harm. A recent study from Australia found that babies exposed to these drugs could face respiratory trouble later in life.

Specifically, the study discovered that antibiotic exposure among babies was associated with allergies and asthma when they become adults.